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LEOPARD syndrome, one of many cardiocutaneous syndromes, is an acronym for some of the obvious manifestations of
the disease, such as lentigines or ocular hypertelorism. The synonymous name progressive cardiomyopathic lentiginosis
better indicates the morbid cardiac features that patients with the syndrome have. A patient with LEOPARD syndrome
is presented. He had recurrent upper extremity aneurysms requiring multiple operations and finally PTFE reinforced
venous grafts to prevent further aneurysmal degeneration. He has multiple other peripheral aneurysms, thus far
asymptomatic. His diagnosis of LEOPARD syndrome was confirmed on a genetic basis. Review of the literature reveals
no previous preports of severe aneurysmal disease in these patients. (J Vasc Surg 2004;39:897-900.)LEOPARD syndrome is one of several cardiocutaneous
syndromes. The name is an acronym for lentigines, electro-
cardiographic conduction defects, ocular hypertelorism,
pulmonary stenosis, abnormal genitalia, retardation of
growth, and sensorineural deafness. In 1976 Voron et al1
summarized the diagnostic criteria for the syndrome. A
patient must have lentigines and at least two of the follow-
ing features: other cutaneous abnormalities, structural car-
diac anomalies, electrocardiographic (ECG) conduction
defects, cardiac symptoms, genitourinary abnormalities,
endocrine findings, neurologic and psychiatric defects,
cephalofacial dysmorphia, shortness of stature, and skeletal
abnormalities. In the absence of lentigines, at least three of
these features and an immediate relative with the character-
istics of the syndrome must be present.1
Our patient met the diagnostic criteria for LEOPARD
syndrome, but had vascular findings not previously known
to be associated with this syndrome.
CASE REPORT
Presentation and surgical treatment. A 32-year-old man
came to us 6 months after repair of a right brachioradial artery
aneurysm at another institution. A 2  3 cm pulsatile mass had
recurred in his right elbow crease, and caused neurologic hand and
forearm symptoms. The aneurysm had initially been repaired with
a saphenous vein graft. An angiogram of the upper extremity
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doi:10.1016/j.jvs.2003.11.030demonstrated a patent graft involved with an anastomotic aneu-
rysm at the radial artery (Fig 1, A) and occlusive disease, and fresh
emboli in the right hand. The aneurysm was repaired with an
interposition reversed greater saphenous vein graft to the ulnar
artery, with exclusion of the radial artery. Two weeks later a large
left brachial artery saccular aneurysm was repaired (Fig 1, B, C)
with a reversed lesser saphenous vein interposition to the ulnar
artery. At these operations and at angiography the dominant ulnar
arteries were found to be normal bilaterally. He recovered un-
eventfully, but 8 months later bilateral ulnar artery aneurysms and
vein graft degeneration developed. Bilateral ulnar artery aneurysm
repair was performed with interposition saphenous vein grafts
reinforced with a polytetrafluoroethylene sleeve (Fig 1, D). Such
sleeves were previously successfully used to avoid kinking and
compression of a saphenojugular bypass graft in a complex case of
superior vena cava syndrome.2 Histologic analysis of the excised
aneurysm vessels was unrevealing.
The patient is under close follow-up, receiving aspirin therapy,
and has remained symptom-free for the past year, without recur-
rent brachial aneurysms on surveillance duplex ultrasound scans.
Vascular workup. The patient’s apparently aggressive aneu-
rysmal disease prompted a thorough investigation. Widespread
disease was found, predominantly in the peripheral vessels. There
were minute aneurysms in some of the right metacarpal vessels (Fig
2, A) and the left superficial palmar arch and in branches of the
subscapular and humeral circumflex arteries (Fig 2, B), and subtle
dilatation and irregularity in a hepatic arterial branch. There were
fusiform aneurysms in the superior and inferior gluteal arteries and
in the obturator artery distribution (Fig 2, C). The right popliteal
artery had prominent irregularity and aneurysms in its muscular
branches, whereas the left exhibited some subtle ectatic changes
(Fig 2, D). Subsequently, aneurysms have developed in peripheral
branches of both deep femoral arteries and in the right geniculate
branches. Recently a computed tomography angiogram demon-
strated aneurysm dilation of the pulmonary outflow tract and of
both main pulmonary arteries.
History and examination. The patient was of French and
Dutch ancestry. Family history was notable only for maternal897
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mal developmental milestones, but early on was noted to have
unusual facies (Fig 3). Diffuse lentigines developed during child-
hood. At the age of 4 years he was found to have a heart murmur
and ECG changes of right ventricular hypertrophy, and underwent
release of the infundibular stenosis of the right ventricle. In addi-
tion, he underwent multiple facial cosmetic procedures and oper-
ative correction of right cryptorchidism.
Examination revealed diffuse lentiginosis that spared the
palms, soles, and buccal mucosa. He had coarse facial features,
downslanting palpebral fissures, and true hypertelorism. He had
moderate macrocephaly. His hearing was normal. He was noted to
have joint hypermobility. The skin was mildly hyperelastic, and
there was normal scar formation. The cardiovascular examination
revealed the heart to be in a regular rhythm, with several systolic
murmurs over the precordium, as well as a mid-systolic to late
systolic apical murmur. He had mild pectus excavatum.
Laboratory tests yielded normal results, and the most recent
ECG showed normal sinus rhythm, biatrial enlargement, and right
bundle branch block and left fascicular block. The echocardiogram
demonstrated normal pulmonary valve function, without recur-
rence of the right ventricular outflow tract obstruction.
Fig 1. A, Recurrent irregular-shaped right brachioradi
ligated at initial repair. B, Saccular aneurysm of the left b
Intraoperative image of left brachial aneurysm at initia
saphenous vein graft to the ulnar artery at third repair.Genetic investigation. Chromosomal analysis and promet-
aphase study of chromosome 6 yielded normal findings. Skin
fibroblast studies suggested no connective tissue disorders.
PTPN11 gene analysis was performed with single-stranded con-
formational polymorphism of the entire coding region, followed
by direct sequencing of the fragments that had an aberrant migra-
tion pattern. Analysis of exon 12 showed a nucleotide transition
1403 C 3 T leading to the substitution of threonine 468 with
methionine. This variation is one of the two recurrent mutations
most often associated with the LEOPARD phenotype.3 There was
no evidence of a contiguous gene deletion.
DISCUSSION
When Gorlin et al4 introduced the term “LEOPARD”
for this cardiocutaneous syndrome over 30 years ago, they
had hoped that “careful family studies would clarify the
minor manifestations of this syndrome.” The authors’ ear-
lier suspicion that until a clinical test allows the exact
diagnosis in affected individuals “it will not be possible to
define the limits of the syndrome” may indeed be closer to
the truth.5 Cases are still being reported with new abnor-
malities in the categories defined by Voron et al.1 Our
ery aneurysm at presentation. Radial branch had been
ial artery at presentation. Note normal ulnar branch. C,
ir. D, Polytetrafluoroethylene sleeve reinforcement ofal art
rach
l repa
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ripheral artery aneurysms. The rarity of each condition
makes the aneurysms more than coincidental findings in
this patient. Authors in the past have suspected the second-
ary effects of the apparent neurocristopathy to give rise to
the widespread mesodermal stigmata of LEOPARD syn-
drome.6 With the new manifestation in our patient, we
reviewed the literature, but turn to the new molecular and
genetic information for an explanation.
The overlap of clinical findings with other cardiocuta-
neous syndromes, such as neurofibromatosis-1, Noonan
syndrome,7 or Watson syndrome,8 makes the differentia-
tion challenging without the availability of laboratory ex-
aminations.
Fig 2. A, Angiogram of right hand demonstrates mult
second metacarpal head (arrowhead). B, Angiogram
subscapular and lateral circumflex humeral arteries (arrow
internal iliac artery (arrowheads). D, Irregularity and ane
and subtle changes on the left (arrowheads).Vascular associations in patients with LEOPARD
syndrome. Vascular lesions are not a known manifestation
of LEOPARD syndrome. They have received incidental
mention in case reports of other patients with this diagno-
sis. Woywodt et al9 wrote of an aneurysm of a femoral vein
in their patient with pacemaker-dependent cardiomyopa-
thy and LEOPARD syndrome. Sutton et al10 noted an
aneurysm of an otherwise normal coronary artery in one of
their 11 patients. A Japanese patient had enlarged pulmo-
nary and coronary arteries.11 A renal arteriovenous shunt
has been reported in a case from Germany.12 Schievink et
al13 described two families with lentigines and cervical
artery dissections in the presence of cystic medial necrosis, a
nonspecific finding common among patients with connec-
igital artery occlusions and an aneurysm overlying the
t periscapular area shows aneurysms supplied by the
s). C, Fusiform aneurysms in the distribution of the right




JOURNAL OF VASCULAR SURGERY
April 2004900 Yagubyan et altive tissue disorders. The neurocristopathy hypothesis, pre-
viously thought to explain many of the features of LEOP-
ARD syndrome, has been considered among Schievink’s
patients inasmuch as the neural crest participates in the
formation of arterial media of the cervical vessels.
PTPN11 gene in LEOPARD syndrome. The
PTPN11 gene was initially mapped to chromosome 12 in
patients with Noonan syndrome.14 The gene encodes for a
non-receptor-type protein tyrosine phosphatase SHP-2.
Since the initial reports of studies of Noonan syndrome,
mutations in different regions of the gene have been found
in patients with LEOPARD syndrome.15
This protein appears to be a participant in multiple
signaling pathways. It modulates cellular proliferation, dif-
ferentiation, and migration, and is thought to explain the
sternal defects and development of a dysplastic pulmonary
valve found in our patient and many other patients with the
syndrome.16 The protein also interacts with the receptor
for angiopoietin 1, purported to be essential in angiogen-
esis and participates in the signaling cascade of the vascular
endothelial growth factor.17 It has a mitogenic effect on
vascular smooth muscle cells under the nitric oxide–in-
duced pathway.18 These interactions may explain the vas-
cular manifestations in our patient.
In conclusion, we report the case of a patient with
LEOPARD syndrome who had multiple peripheral vascu-
lar aneurysms, a hitherto unreported finding of this syn-
drome. The PTPN11 mutation may explain this new find-
ing and the remaining manifestations of the syndrome. We
must await better delineation of the functions of the phos-
phatase product of this gene, as well as those of other
Fig 3. Lentigines and hypertelorism apparent on facial photo-
graph.genetic mutations, to help classify the various cardiocuta-
neous syndromes and for better genotype-phenotype cor-
relations.
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